IRIS
FERRARI, GIULIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 550
NA - Nord America 432
AS - Asia 34
AF - Africa 3
OC - Oceania 3
Totale 1.022
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 430
SE - Svezia 421
IT - Italia 55
FI - Finlandia 23
IE - Irlanda 19
DE - Germania 18
IN - India 11
CN - Cina 8
JP - Giappone 7
AU - Australia 3
ES - Italia 3
ET - Etiopia 3
FR - Francia 3
GB - Regno Unito 3
TR - Turchia 3
CA - Canada 2
CH - Svizzera 2
BD - Bangladesh 1
BE - Belgio 1
HK - Hong Kong 1
ID - Indonesia 1
NL - Olanda 1
PH - Filippine 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 1.022
Salva come PNG Salva come JPEG
Città #
Lawrence 114
Princeton 114
Ashburn 104
Milan 39
Helsinki 23
Dublin 19
New York 17
Pune 10
Seattle 5
Shanghai 4
Washington 4
Aksum 3
Ankara 3
Barcelona 3
Borås 3
Hanover 3
Turin 3
Düsseldorf 2
Indianapolis 2
Linfen 2
Los Angeles 2
Sigmaringendorf 2
Sydney 2
Tokyo 2
Vauderens 2
Vigonza 2
Albuquerque 1
Andover 1
Angers 1
Asti 1
Boardman 1
Bogor 1
Cambridge 1
Conshohocken 1
Dreieich 1
Durham 1
Easley 1
Geislingen an der Steige 1
Kochi 1
Marikina City 1
Modena 1
Monza 1
Moscow 1
Mountain View 1
Naaldwijk 1
Napoli 1
Old Westbury 1
Pordenone 1
Ronkonkoma 1
Schaarbeek 1
Stockholm 1
Sunshine Coast 1
Toronto 1
Upland 1
Yangquan 1
Totale 518
Salva come PNG Salva come JPEG
Nome #
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation 28
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 21
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 20
Correcting b-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity 18
NCOA4-mediated ferritinophagy in macrophages is crucial to sustain erythropoiesis in mice 17
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 16
A clinical protocol for transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA deficient SCID 15
A human PBL immunodeficient mouse model for in vivo preclinical studies of human gene therapy. 15
Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to Plerixafor alone 15
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 15
Strain polymorphism and tentative mapping of mouse ornithine decarboxylase 14
Bone marrow as an alternative site for islet transplantation 14
Gene therapy using haematopoietic stem and progenitor cells 14
A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers 13
Transcription factor binding sites as genetic determinants of retroviral integration in the human genome 13
Aberrant, noninfectious HIV-1 particles are released by chronically infected human T cells transduced with a retroviral vector expressing an interfering HIV-1 variant 13
Bone marrow as an alternative site for islet transplantation 13
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 13
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4 13
Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer 13
A Highly conserved SOX6 double binding site mediates SOX6 gene downregulation in erythroid cells 12
Clinical protocol: transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID 12
Selective engraftment of genetically modified hematopoietic stem cells by a truncated erythropoietin receptor 12
Characterization of Papilloma virus polypeptides from bovine cutaneous fibropapillomas 12
A non-producer interfering HIV-1 provirus can be transduced through a MLV-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus 12
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 12
Clonal analysis of stably transduced human epidermal stem cells in culture 12
Failure to correct murine muscular dystrophy 11
Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement 11
T-cell receptor genes in tassel-eared squirrels (Sciurus aberti). I. Genetic polymorhism and divergence in the Abert and Kaibab subspecies 11
Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer 11
Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activity 11
The second transferrin receptor regulates red blood cell production in mice 11
Bone marrow-derived stem cells repopulate glomerular and tubular kidney components - Effect of hyperglycemia 11
In vivo and in vitro models for the analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency. 11
Terapia genica e malattia ereditaria 11
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 11
TRANSFER OF THE HSV-TK GENE INTO DONOR PERIPHERAL-BLOOD LYMPHOCYTES FOR IN-VIVO IMMUNOMODULATION OF DONOR ANTITUMOR IMMUNITY AFTER ALLO-BMT 11
Strain specific retroviral sequences are anomalously represented in DNA of mouse lymphomas 11
Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice 11
The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity 10
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy? 10
Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo 10
Deletion of a negatively acting sequence in a chimeric GATA-1 enchancer-LTR greatly increases retroviral-mediated erythroid expression 10
Down-regulation of SPARC/osteonectin/BM-40 expression in methylcholanthrene-induced fibrosarcomas and in Kirsten-MSV transformed fibroblasts 10
Retroviral vector gene-transfer into donor peripheral-blood lymphocytes for in-vitro selection and in-vivo immunomodulation of donor antitumor immunity after allo-BMT 10
Transfer of the ADA gene into human ADA-deficient T Lymphocytes reconstitutes specific immune functions 10
Safety of retroviral gene marking with a truncated NGF receptor 10
Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: Evidence from a murine model 10
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27 10
Retroviral heterogeneity in mouse lymphomas 10
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency 10
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 9
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets 9
Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo 9
Muscle regeneration by bone marrow-derived myogenic progenitors 9
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement 9
The GATA1-HS2 Enhancer allows persistent and position-independent expression of ß-globin transgene 9
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 9
Persistent and Position Independent Transgene Expression in Erythroid Cells Transduced 9
Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA- Immunodeficient Patients 9
Gene-transfer into peripheral-blood lymphocytes for in-vivo immunomodulation of donor antitumor immunity in a patient affected by EBV-induced lymphoma 9
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy 9
Gene Therapy Approaches to Hemoglobinopathies 9
Myogenic conversion of mammalian fibroblasts induced by differentiating muscle cells 9
Gene transfer into human primary myogenic cells. 9
Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease 9
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 9
Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans 8
Transcript imaging of human T helper cell development using oligonucleotide arrays 8
Genetic modification of somatic stem cells. The progress, problems and prospects of a new therapeutic technology 8
Phosphorylation of synapsin I by cAMP-dependent protein kinase controls synaptic vesicle dynamics in developing neurons. 8
Report on the 2nd annual meeting of the European Working Group on Human Gene Transfer and Therapy, London, November 18-21, 1994 8
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptor 8
When diagnostics meets translational research: detection of hemoglobin fractions in cellular lysates from in vitro erythroid cultures by Capillarys2 Flex Piercing® analyzer (Sebia) 8
In vivo and in vitro models for analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency 8
Vector design influences retroviral integration in human hematopoietic cells 8
Terapia Genica 8
Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy 8
The influence of vector design on integration site selection by gamma-retroviral and lentiviral vectors 8
Preclinical Assessment of a Gene Therapy Approach to beta-Thalassemia 8
Conditioning Regimens in Long-Term Pre-Clinical Studies to Support Development of Ex Vivo Gene Therapy: Review of Nonproliferative and Proliferative Changes 8
Hypomorhic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype 8
Retroviral vectors for human gene therapy 8
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease 7
Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia 7
Safety of retroviral gene marking with a truncated NGF receptor 7
Stem cell plasticity: time for a reappraisal? 7
Correction of ß-thalassemia major by gene transfer in hematopoietic progenitors of pediatric patients 7
Gene therapy for beta-thalassemia: analysis of therapeutic efficiency in pre-clinical models 7
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 7
Pancreatic islets recruit mesenchymal stem cells by release of chemokines 7
Gene therapy for beta thalassemia: preclinical studies on human cells 7
Gene therapy and gene editing strategies for hemoglobinopathies 7
Retroviral vectors for human gene therapy 7
Reversible Immortalization of Human Myogenic Cells by Site-Specific Excision of a Retrovirally Transferred Oncogene 6
Hot spots of retroviral integration in human CD34+ hematopoietic cells 6
High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies 6
Transcription Factor Binding Sites Are Genetic Determinant of Retroviral Integration in the Human Genome 6
Towards the correction of the genetic defect in corneal keratinocytes from patients with macular corneal dystrophy type II 5
Totale 1.038
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 2 0 0 0 0 0 0 0 1 0 1 0
2020/202112 1 0 0 1 0 7 2 0 1 0 0 0
2021/2022112 0 0 0 43 0 2 1 51 4 5 1 5
2022/2023697 259 172 46 5 2 100 25 53 17 9 6 3
2023/2024259 10 20 31 105 19 45 11 5 0 7 6 0
Totale 1.120